XPOT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.935000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.670200E-01
Normal-vs-Stage2
6.742200E-01
Normal-vs-Stage3
1.477170E-01
Normal-vs-Stage4
4.818000E-01
Stage1-vs-Stage2
5.236800E-01
Stage1-vs-Stage3
6.764200E-02
Stage1-vs-Stage4
6.937400E-01
Stage2-vs-Stage3
1.717600E-01
Stage2-vs-Stage4
9.018600E-01
Stage3-vs-Stage4
7.094400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.698400E-01
Normal-vs-AfricanAmerican
5.867200E-01
Normal-vs-Asian
4.710800E-01
Caucasian-vs-AfricanAmerican
9.364000E-01
Caucasian-vs-Asian
8.038100E-02
AfricanAmerican-vs-Asian
1.245960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.496400E-01
Normal-vs-Female
7.460800E-01
Male-vs-Female
5.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.177800E-01
Normal-vs-Age(41-60Yrs)
4.044800E-01
Normal-vs-Age(61-80Yrs)
8.698200E-01
Normal-vs-Age(81-100Yrs)
6.580800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.313800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.652400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.079800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.802500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.999800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.775800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.720200E-01
Normal-vs-Daily Drinker
8.678400E-01
Normal-vs-Weekly Drinker
7.885000E-01
Normal-vs-Occasional Drinker
5.101000E-01
Normal-vs-Social Drinker
4.989400E-01
Non Drinker-vs-Daily Drinker
9.421800E-01
Non Drinker-vs-Weekly Drinker
4.555000E-01
Non Drinker-vs-Occasional Drinker
9.366500E-02
Non Drinker-vs-Social Drinker
1.111640E-01
Daily Drinker-vs-Weekly Drinker
4.192600E-01
Daily Drinker-vs-Occasional Drinker
9.581600E-02
Daily Drinker-vs-Social Drinker
9.205800E-02
Weekly Drinker-vs-Occasional Drinker
5.292000E-01
Weekly Drinker-vs-Social Drinker
4.840800E-01
Occasional Drinker-vs-Social Drinker
8.918200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.641600E-01
Normal-vs-Grade 2
9.563400E-01
Normal-vs-Grade 3
9.092400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.560200E-01
Grade 1-vs-Grade 3
2.240600E-01
Grade 1-vs-Grade 4
9.641600E-01
Grade 2-vs-Grade 3
3.929000E-01
Grade 2-vs-Grade 4
9.563400E-01
Grade 3-vs-Grade 4
9.092400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.696200E-01
Normal-vs-NonDiabetic
8.448400E-01
Diabetic-vs-NonDiabetic
7.446800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.518200E-01
Normal-vs-NoPancreatitis
7.801400E-01
Pancreatitis-vs-NoPancreatitis
6.501600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.633000E-01
Normal-vs-N1
6.518400E-01
N0-vs-N1
5.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.289000E-01
Normal-vs-TP53-NonMutant
6.706600E-01
TP53-Mutant-vs-TP53-NonMutant
1.095610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
